Search Results for
“Telegram Expert 是 什么✅SMMFS.COM✅tg粉飞机涨粉,nVV”
March 8, 2022
The Canadian Institutes of Health Research (CIHR) is seeking members for its new Standing Committee on Science. The committee will have a diverse membership made up of nationally and internationally […]
April 8, 2019
Members in action Did you know? ASBMR Osteoporosis Canada will be releasing updated Osteoporosis Management Clinical Guidelines in the fall of 2019. Along with a steering committee, working groups have […]
September 26, 2023
THE CMC 2023 COMMITTEE CHAIR: Dr. Rowena RidoutVice Chair: Dr. Claudia Gagnon SCIENTIFIC COMMITTEE MEMBERS Dr. Rowena Ridout Dr. Claudia Gagnon Dr. Heather McDonald Blumer Dr. Heather Frame Dr. Sandra […]
February 9, 2024
Latest News IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies February 9, 2024 Following the elections held for the position of Chair of the International […]
January 22, 2008
Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]
October 13, 2021
Osteoporosis Canada is pleased to share that long-time volunteer Dr. Hilary Jaeger is one of three leaders recognized as Honorary Fellows of the Royal College for her transformative contributions to […]
June 7, 2019
SCIENTIFIC ADVISORY COUNCIL We look to the best experts to inform our care guidelines for patients and care providers. Our Scientific Advisory Council (SAC) is made up of experts in […]
![](https://osteoporosis.ca/wp-admin/admin-ajax.php?action=kernel&p=image&src=%7B%22file%22%3A%22wp-content%2Fuploads%2FWEBINAR-1-3-MANAGING-OSTEOPOROSIS-PATIENTS-DURING-COVID-19.jpg%22%2C%22thumbnail%22%3A%22%2C%2C%22%7D&hash=7a933b3f)
June 1, 2020
This webinar featured an expert panel and was intended for Healthcare Professionals on managing osteoporosis patients during COVID-19. View this thought-provoking discussion focusing on challenges and solutions for managing your […]
November 11, 2010
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]